---
title: "Vault Domain Knowledge — Arxiv Autosota Research Automation Rscf"
type: reference
source: 07_SKILLS/arxiv-autosota-research-automation-rscf/references
tags: [reference, arxiv-autosota-research-automation-rscf, canon/skill]
rscf:
  state: SOURCE_CLAIM
  claim_class: SOURCE_CLAIM
  provenance: AMOS_corpus
  scope: skill_reference
---


# Vault-Sourced Domain Knowledge

> Source: AMOS_OS Obsidian vault (`_00_Cosmo brain/`)
> Epistemic class: SOURCE_CLAIM
> Extracted from skill: `arxiv-autosota-research-automation-rscf`

## Vault-Sourced Content

### Source 1: Enhanced AI Sweet Spots Research Paper

> Path: `misc/E/Enhanced AI Sweet Spots Research Paper.md` | Size: 18856 chars | Match score: 10

AI Sweet Spots: Differential Cognitive Effects of Generative AI
Across Neurotypical, Neurodivergent, Twice-Exceptional, Elderly,
and Culturally Diverse Populations
Abstract
Background: Recent neuroscientific evidence demonstrates that generative artificial intelligence (AI)
tools induce "cognitive debt" in neurotypical users, reducing neural engagement and memory recall
during writing tasks by 20-30%. However, this finding assumes cognitive homogeneity across human
populations.
Objective: To develop and validate the AI Sweet Spot Model—a framework mapping optimal AI
involvement levels across five distinct cognitive populations to maximize effectiveness while
minimizing workload.
Methods: Systematic evidence synthesis across PubMed, PsycINFO, IEEE Xplore, and arXiv (2020-
2025) examining AI assistance, cognitive load, and performance. We analyzed neurotypical (N=54),
ADHD (N=633), autism spectrum (N=240), dyslexic (N=200), twice-exceptional (N=50), and elderly
(N=400,000+) populations using dual-axis measurement of cognitive effectiveness and workload
against AI involvement percentage.
Results: Optimal AI involvement varies systematically: neurotypical users peak at 20-35%, ADHD
users at 40-70% (often exceeding neurotypical performance), dyslexic users show immediate gains
from minimal support, twice-exceptional learners exhibit dual optimization peaks, and elderly users
benefit from prosthetic-level assistance at 35-60%. Cultural contexts shift effectiveness curves
independently of cognitive factors.
Conclusions: The assumption of universal AI impact on human cognition is false. Neurodivergent
populations often achieve superior performance through AI scaffolding at levels that impair
neurotypical users. These findings necessitate differentiated AI policies in education, workplace
optimization for neurodivergent talent, and culturally responsive AI design.
Keywords: artificial intelligence, cognitive diversity, neurodivergence, human-computer interaction,
cognitive load theory, differential optimization
1. Introduction
1.1 The Cognitive Debt Problem
The proliferation of large language models (LLMs) has created unprecedented opportunities to study
human-AI cognitive interaction at scale. Recent neurophysiological research from MIT provides a

concerning baseline: when neurotypical adults used ChatGPT for essay writing, EEG measurements
revealed:
20% reduced neural connectivity in attention-related frequency bands
30% impaired recall of self-generated content
25% diminished authorship ownership compared to unassisted writing
Persistent effects continuing after return to solo work
These "cognitive debt" effects suggest adaptive neural changes toward reduced effort allocation
(Kos'myna et al., 2025), catalyzing debate about AI's universal impact on human intelligence.
1.2 The Cognitive Homogeneity Assumption
Current interpretations of cognitive debt assume all brains respond identically to technological
scaffolding. This assumption contradicts substan

---

### Source 2: AMOS Automation Kernel vInfinity

> Path: `kernel/A/AMOS Automation Kernel vInfinity.md` | Size: 13164 chars | Match score: 10

# AMOS Automation Kernel vInfinity

## Meta
- **Engine**: AMOS_AUTOMATION_ENGINE_v2.0.0
- **Version**: 2.0.0
- **Source Files**: AMOS_SUPER_CODE_Engine_v1.6.0.json, Tech_Engine_vInfinity_MAX.json, Design_Engine_v4.0.0.json
- **Schema**: combined_engine_bundle
- **Description**: Unified, self-auditing automation OS combining SUPER_CODE, Tech vInfinity MAX, and Design v4.0.0 engines with full integration scaffolding, benchmarking, and n8n-style workflow orchestration primitives.

## Enhancements (5)
1. Self-audit pipeline for every automation run (design, code, infra, data)
2. Benchmarking contract for reliability, latency, cost, and safety across workflows
3. First-class integration model for n8n, Zapier, Make, and generic webhook-based tools
4. Extensible automation pattern library (30+ blueprints) with parameter schemas
5. Auto-repair and retry orchestration with graded fallbacks and human-in-the-loop hooks

---

## SUPER_CODE_ENGINE (Unified_Coding_Engine_vInfinity v1.6.0)

### Capability Flags (15)
All fully specified: architecture, runtime, testing, memory, self_correction, routing, language_control, governance, architecture_layer, documentation_layer, estimation_planning_layer, change_impact_layer, api_contract_layer, scope_excludes_theoretical_ai_research, infrastructure_support_is_advisory

### 9 Core Layers

#### 1. Runtime Layer (2 Functions)
- **observe_runtime_signals**: Ingest logs, metrics, error events → runtime_health_summary, suspected_failure_points, candidate_signals_to_instrument
- **derive_execution_gaps**: Find missing checks, branches, unhandled states → execution_gap_list, prioritised_runtime_fix_list

#### 2. Testing Layer (3 Functions)
- **generate_test_matrix**: Full test matrix for unit/integration/E2E → test_case_catalog, coverage_matrix, risk_based_prioritisation
- **generate_test_code**: Concrete test code for priority cases → unit_test_files, integration_test_files
- **interpret_test_results**: Map failing tests to defects → defect_hypotheses, candidate_patches, regression_risk_analysis

#### 3. Memory Layer (2 Functions)
- **build_project_memory_snapshot**: Summarise architecture → project_memory_object, memory_index_keys
- **update_memory_from_change_set**: Update memory from code diffs → updated_project_memory_object

#### 4. Self-Correction Layer (2 Functions)
- **propose_patches_from_runtime_and_tests**: Safe patches from runtime evidence + failing tests → patch_plan, ordered_patch_steps, risk_notes_per_patch
- **generate_patch_diff**: Generate diff patches → unified_diff, per_file_patch_summaries

#### 5. Architecture Layer (3 Functions)
- **derive_entity_state_model**: Entity-state-transition model from requirements → entity_state_model, key_events_and_transitions
- **design_system_components**: Services, modules, interfaces → component_diagram, interface_contracts, architecture_rationale
- **architecture_risk_review**: Scalability, reliability, security, change risk → architecture_risk_list, mitigation_recom

---

### Source 3: AMOS_Clinical_Research_Kernel_v0_Biology_Cognition7_3

> Path: `kernel/A/AMOS_Clinical_Research_Kernel_v0_Biology_Cognition7_3.md` | Size: 2702 chars | Match score: 10

{
  "meta": {
    "name": "Clinical_Research_Kernel",
    "version": "1.0.0",
    "description": "Kernel for clinical research: trial design, conduct, analysis, and reporting."
  },
  "kernel": {
    "description": "Supports clinical research: trial design, protocol development, regulatory compliance, data collection, analysis, and reporting per CONSORT and other guidelines.",
    "functions": {
      "trial_design": {
        "description": "Design a clinical trial.",
        "inputs": ["research_question", "intervention", "population", " comparators", "primary_outcome", "regulatory_pathway"],
        "outputs": ["trial_design_summary", "phase_determination", "randomisation_scheme", "blinding_plan", "endpoint_selection"]
      },
      "protocol_development": {
        "description": "Develop a clinical trial protocol.",
        "inputs": ["trial_design", "ICH_GCP_requirements", "ethical_considerations", "statistical_plan", "operational_plan"],
        "outputs": ["protocol_document_outline", "informed_consent_requirements", "data_management_plan", "safety_monitoring_plan"]
      },
      "regulatory_compliance": {
        "description": "Check regulatory and ethical compliance.",
        "inputs": ["trial_details", "jurisdiction", "submission_pathway", "vulnerable_population_involvement"],
        "outputs": ["compliance_checklist", "IRB/ethics_requirements", "regulatory_submission_needs", "risk_based_monitoring_plan"]
      },
      "results_reporting": {
        "description": "Report trial results per CONSORT and other guidelines.",
        "inputs": ["trial_results", "consort_checklist", "subgroup_analyses", "adverse_events", "limitations"],
        "outputs": ["consort_flow_diagram_description", "results_summary", "adverse_event_summary", "interpretation_and_limitation"]
      }
    },
    "capabilities": {
      "trial_phases": "Phase I (safety), Phase II (dose-finding/efficacy signal), Phase III (confirmatory), Phase IV (post-market).",
      "design_types": "Parallel, crossover, factorial, cluster, adaptive, basket, umbrella.",
      "ethical_frameworks": "Declaration of Helsinki, ICH GCP E6(R2), CIOMS guidelines, Belmont Report principles.",
      "reporting_guidelines": "CONSORT, SPIRIT, PRISMA, STROBE, STARD, ICH E3.",
      "data_management": "Case report forms, data validation, SAE reporting, data monitoring committees."
    }
  }
}

---

---
**MOC:** [[references_MOC]]

## Related

- [[07_SKILLS_MOC]]
